Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Hims & Hers Health Inc shares valued at $271,349 were sold by Becklund Irene on May 22 ’25. At $53.51 per share, Becklund Irene sold 5,071 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, Melissa Baird purchased 33,333 shares, netting a total of over 1,778,649 in proceeds.
Before that, Boughton Soleil had added 3,233 shares to its account. In a trade valued at $180,628, the Officer bought Hims & Hers Health Inc shares for $55.87 each.
As published in a research note from TD Cowen on April 29, 2025, Hims & Hers Health Inc [HIMS] has been rated down from a Buy to a Hold and the price target has been revised to $30. Analysts at Morgan Stanley downgraded the stock from ‘”an Overweight”‘ to ‘”an Equal-weight”‘ outlook in a report released in mid February. As of January 10, 2025, Citigroup has decreased its “Neutral” rating to a “Sell” for HIMS. Earlier on January 07, 2025, BTIG Research initiated its rating. Their recommendation was “a Buy” for HIMS stock.
Analyzing HIMS Stock Performance
During the last five days, there has been a drop of approximately -12.86%. Over the course of the year, Hims & Hers Health Inc shares have jumped approximately 120.60%. Shares of the company reached a 52-week high of $72.98 on 02/19/25 and a 52-week low of $23.97 on 04/04/25.
Support And Resistance Levels for Hims & Hers Health Inc (HIMS)
According to the 24-hour chart, there is a support level at 51.80, which, if violated, would cause prices to drop to 50.27. In the upper region, resistance lies at 54.48. The next price resistance is at 55.63. RSI (Relative Strength Index) is 56.22 on the 14-day chart, showing neutral technical sentiment.
